AIIMS Delhi, IIT Delhi to establish Center of Excellence for AI in healthcare

16

New Delhi, June 4 (IANS) The All-India Institute of Medical Sciences (AIIMS) on Wednesday announced signing a partnership agreement with the Indian Institute of Technology (IIT) Delhi to establish a Center of Excellence for artificial intelligence in healthcare (AI-CoE).

The AI-CoE will focus on developing AI-based solutions for supporting key national health programmes in the country.

“This MoU marks the beginning of far-reaching collaborative research that has the potential to change the face of healthcare in the country,” said Prof. M. Srinivas, Director, of AIIMS Delhi.

“A partnership between AIIMS and IIT Delhi has the potential to transform AI for affordable healthcare. We are delighted to be shaping this national centre of excellence and hope that our output will impact the lives of Indians,” added Prof. Rangan Banerjee, Director, of IIT Delhi.

The Memorandum of Understanding (MoU) was signed by Prof Srinivas, and Prof. Banerjee at a ceremony held at IIT Delhi.

Last year, the two institutes were awarded a grant of Rs 330 crore by the Ministry of Education under the initiative “Make AI in India, Make AI Work for India,” following a rigorous and highly competitive selection process.

The proposed Centre of Excellence will be the executing vehicle for the grant.

The project aims to keep patients at the centre of and to build mechanisms that would benefit every citizen of the country.

The CoE will serve as a key research and resource center at the national and international level and aims to revolutionise the national public health system using indigenously developed AI systems and solutions, said the experts.

“We aim to develop cutting-edge AI solutions to upscale health services, upskill our healthcare providers, and improve the accessibility of quality healthcare to remote and marginalised sections of our population,” said Prof. Chetan Arora, Chief Project Manager, who will lead the AI-CoE from IIT Delhi.

IIT Delhi and AIIMS Delhi have a history of strong research collaboration, including the Centre for Advanced Research and Excellence in Disability & Assistive Technology (CARE-DAT) which is working to develop assistive technologies for persons with disabilities.

–IANS

rvt/

Go to Source

Disclaimer

The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.

Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.

For any legal details or query please visit original source link given with news or click on Go to Source.

Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.

If you are not willing to accept this disclaimer then we recommend reading news post in its original language.

MGID